Johnson & Johnson (BVL:JNJ)

Peru flag Peru · Delayed Price · Currency is PEN · Price in USD
224.30
0.00 (0.00%)
Last updated: Feb 16, 2026, 9:30 AM PET
Market Cap1.98T +45.6%
Revenue (ttm)317.38B +6.0%
Net Income90.32B +90.6%
EPS37.17 +90.5%
Shares Outn/a
PE Ratio21.88
Forward PE21.02
Dividend18.28 (8.15%)
Ex-Dividend DateNov 25, 2025
Volumen/a
Average Volume57
Open224.30
Previous Close224.30
Day's Range224.30 - 224.30
52-Week Range150.69 - 224.30
Betan/a
RSI99.98
Earnings DateJan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,200
Stock Exchange Lima Stock Exchange
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2025, Johnson & Johnson's revenue was $94.19 billion, an increase of 6.05% compared to the previous year's $88.82 billion. Earnings were $26.80 billion, an increase of 90.56%.

Financial numbers in USD Financial Statements